How Risky Is Tear Trough Filler, and Who Is a Good Candidate?

How risky is tear trough filler?

For most people, tear trough filler causes bruising, swelling and tenderness that often fade within about a week, though some last longer. In a 2024 meta-analysis, swelling occurred in 19.2% of patients, bruising in 18.4%, lumps or contour irregularity in 5.3% and a blue Tyndall effect in 0.9%. Serious events are rare, but they do happen.

The FDA trials tell a similar story. In the Restylane Eyelight trial, people kept a 28-day diary: 89.7% noted tenderness and 85.0% noted swelling. Most of these events were rated tolerable, and more than 63% cleared within 7 days. In the Juvederm Volbella XC trial for the same area, 56.3% reported an injection site response after the first treatment, mostly mild, and most cleared within a week. Treatment-related swelling judged by the doctors running each trial was far less common, 3.8% in both.

Two risks are more specific to this area. The first is delayed swelling: a 2022 systematic review of 52 published cases of late tear trough complications found swelling was the most common problem (42.3%), followed by lumps or nodules (25.0%), and complications appeared on average 16.8 months after treatment. The second is a blue-gray tint, often called the Tyndall effect, that can show through the thin skin under the eye.

The most serious risk is injection into a blood vessel. The FDA warns that this can cause tissue death, blindness or stroke, and that the harm may be permanent. The area around the eyes is among the places it has been reported most often: the FDA summary for Restylane Eyelight names the periorbital area, along with the nose, the area between the brows, the smile lines and the cheeks. Rare does not mean impossible, which is why training in this area matters.

What does a tear trough filler do, and how long does it last?

Tear trough filler places a small amount of hyaluronic acid gel in the hollow where the lower eyelid meets the cheek, so the area casts less shadow and looks less tired. It does not tighten skin or remove bags. The Restylane Eyelight patient labeling says its effect has been shown to last up to 12 months.

Trial data show how the effect fades. In the Eyelight trial, 87.4% of treated people were responders at 3 months, compared with 17.7% of untreated controls, and the share fell to 86.0% at 6 months, 77.6% at 9 months and 63.5% at 12 months. In the Volbella XC trial, 83.1% were responders at 3 months and 73.4% at 12 months. A responder improved by at least one grade on the trial's hollowness scale, judged by a blinded evaluator.

Satisfaction tends to be high when the patient fits the treatment: the 2024 meta-analysis put pooled satisfaction at 91.0%. Your own timeline depends on the product and on how your face keeps changing, so think of under-eye filler as maintenance rather than a one-time fix, and ask what a repeat visit would involve before you start.

Is tear trough filler the same as under-eye filler?

Mostly, yes. Tear trough filler and under-eye filler are everyday names for the same treatment. The FDA's term is infraorbital hollowing, and the Eyelight trial defined the area as the junction of the lower eyelid and midface where a volume deficit has formed, between the side of the nose and the outer bony rim of the eye socket.

As of October 2026, four hyaluronic acid fillers carry an FDA indication for this area in adults over 21. Juvederm Volbella XC was approved for improvement of infraorbital hollowing on May 28, 2021, Restylane Eyelight followed on May 8, 2023, Belotero Balance (+) Lidocaine on September 27, 2023, and RHA Redensity Eye on May 12, 2026. Any other filler placed under the eyes is used off-label, meaning that product is not FDA-approved for that use, and the FDA notes that the risks of unapproved uses are not known.

Labels are product-specific: the FDA's general filler page, last updated in July 2023, still lists the periorbital area among unapproved uses. So ask two questions at your consultation: which product will be used, and does its label include the under-eye area? Derm Clinic MD offers under-eye filler, and the under-eye filler page covers the basics. Our dermal fillers page lists the filler families the practice uses. If a plan involves an off-label product, you should hear that plainly, along with the reason for it.

Is it a hollow, a bag or dark pigment?

Filler helps a hollow, the shadowed groove under the eye. It does not remove puffy bags, and it does not change brown pigment. Dark circles can come from shadow, extra pigment or blood vessels showing through thin skin, and each cause points toward a different kind of treatment, so the first job is working out which one you have.

The Eyelight trial is a useful filter because of who it left out. It excluded people whose dark circles came from pigment rather than hollow shadowing, people prone to eyelid swelling, people with festoons, and people with large or bulging under-eye fat pads. That does not prove filler harms these groups, but it does mean the FDA data do not cover them.

Many people have a mix. A 2023 review in Aesthetic Surgery Journal Open Forum notes that hollows often overlap with malar mounds, festoons and dark circles, and that adding volume to the midface can improve the under-eye area too. That is why an injector may suggest starting with the cheeks, an option our cheek filler guide explains in more detail.

What is eyebag filler?

Eyebag filler is a marketing phrase, not a medical term. Filler cannot remove a bag. Some injectors place filler in the hollow below a small bag to blend its edge so it stands out less, but the evidence for that is thin, and larger bulging fat pads usually lead to a conversation with a surgeon.

The available data come from small studies. A 2025 prospective study of 26 patients treated for lower eyelid bags with hyaluronic acid filler reported that 25 of 26 were satisfied at 2 and 6 months. Only a subset was followed longer, and results had held at 16 months in 5 people (19.2% of the group). Mild swelling was common and took up to 60 days to settle, and one person needed hyaluronidase. There was no control group, and the author called for controlled studies.

Surgery is a separate path, handled by surgeons. The 2023 review in Aesthetic Surgery Journal Open Forum lists lower eyelid blepharoplasty, with fat transposition or injections, among the surgical options for this area. If your bags are large, an honest consultation should say so and point you toward a surgeon instead of trying to camouflage them with filler.

Why shouldn't some people get under-eye filler?

Under-eye filler is a poor fit if your main issue is puffiness, pigment or loose skin, or if your health history raises the risk. The Restylane Eyelight labeling rules it out for people with severe allergies or an allergy to lidocaine, and its trial excluded people with chronic under-eye swelling, rosacea or uncontrolled severe seasonal allergies.

The allergy point matters here. Atlanta's spring pollen season can be hard on allergic eyes, and the Eyelight trial excluded people with uncontrolled severe seasonal allergies as well as chronic under-eye swelling. If your eyes swell every spring, say so at your consultation, and expect a conversation about timing, or about whether the area is right for you at all. Planning your visit for a stretch when your allergies are under control gives you and your injector a clearer starting point.

The Eyelight patient labeling lists more to discuss: medicines that suppress the immune system, a history of thick scars or pigment disorders, recent laser treatments or peels, blood thinners such as aspirin and warfarin, and any permanent implant near the under-eye. It also says the product should be injected only by doctors who have completed training for this area.

• Chronic under-eye swelling, rosacea or uncontrolled severe seasonal allergies
• A lower lid that sits low, or eyes that bulge forward
• Large or bulging under-eye fat pads, festoons or a tendency to eyelid swelling
• Dark circles caused by pigment rather than shadow
• Pregnancy or breastfeeding, where safety has not been studied
• Sores, pimples, rashes or infection in the area

What happens if under-eye filler goes wrong?

Most problems with hyaluronic acid under-eye filler can be treated, often with hyaluronidase, an enzyme that breaks down the gel. A 2024 review in JMIR Dermatology describes its use for nonurgent problems like the Tyndall effect and nodules, and immediate treatment for a blocked blood vessel. Vision loss is the exception: it often cannot be reversed.

Delayed swelling is the problem people least expect. The FDA summary for Restylane Eyelight notes that late reactions, such as inflammation appearing more than 2 years after treatment, have been reported in low numbers in the under-eye area. In the Volbella XC trial, 3 people had mild swelling more than 30 days after treatment, and all resolved within 45 days, one with antibiotics. If an older under-eye treatment starts to puff, see your injector before anyone adds more filler. You can read how dissolving filler works.

Speed matters with a blocked vessel, and even fast care has limits. A 2025 American Academy of Ophthalmology review of 198 cases of vision loss after filler found that emergency treatments, including hyaluronidase, were usually not effective in reversing it, and vision was no better at the end in 70% of the 196 cases with follow-up. Seek immediate medical attention for vision changes, unusual pain during or shortly after treatment, skin that turns white, or signs of a stroke such as face drooping, trouble speaking or sudden weakness.

If you want a clear answer for your own face, book a consultation at our Buckhead or Cumming office to learn whether your under-eyes show a hollow, a bag or something else, and which options fit, including doing nothing for now.

This article is general education and is not medical advice. It does not replace an in-person consultation. Whether a treatment suits you, and what result is realistic, depends on your health history and an examination.

Derm Clinic MD · Last updated October 2026.